Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review

References

• Center for Disease Control and Prevention . Available from: www.cdc.gov/nchs/data/dvs/deaths_2010_release.pdf [Accessed 17 April 2013]
   Google Scholar
• American Diabetes Association . Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36(4):1033-46
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention (CDC) . National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA; 2008. Available from: www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf [Accessed 16 October 2013]
   Google Scholar
• Phung OJ , Schwartzman E , Allen RW , et al. Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis. Diabet Med 2013;30(10):1160-71
   PubMed Web of Science ®Google Scholar
• Wheeler S , Moore K , Forsberg CW , et al. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Forst T , Hanefeld M , Jacob S , et al. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies. Diab Vasc Dis Res 2013;10(4):302-14
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group . Gerstein HC , Miller ME , et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358(24):2545-59
   PubMed Web of Science ®Google Scholar
• Kheirbek RE , Alemi F , Zargoush M . Comparative effectiveness of hypoglycemic medications among veterans. J Manag Care Pharm 2013;19(9):740-4
   PubMed Web of Science ®Google Scholar
• Luijks H , Schermer T , Bor H , et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 2012;10:128
   PubMed Web of Science ®Google Scholar
• Song SH , Hardisty CA . Early onset type 2 diabetes mellitus: a harbinger for complications in later years – clinical observation from a secondary care cohort. QJM 2009;102(11):799-806
   PubMed Web of Science ®Google Scholar
• Jurado J , Ybarra J , Solanas P , et al. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. J Am Acad Nurse Pract 2009;21(3):140-8
   PubMed Web of Science ®Google Scholar
• Zhang X , Decker FH , Luo H , et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc 2010;58(4):724-30
   PubMed Web of Science ®Google Scholar
• Gee ME , Janssen I , Pickett W , et al. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009. Can J Cardiol 2012;28(3):367-74
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan M , He G , Stoddard P , Schillinger D . Blood pressure control, hypertension, awareness, and treatment in adults with diabetes in the United States-Mexico border region. Rev Panam Salud Publica 2010;28(3):164-73
   PubMed Web of Science ®Google Scholar
• Zekry D , Frangos E , Graf C , et al. Diabetes, comorbidities and increased long-term mortality in older patients admitted for geriatric inpatient care. Diabetes Metab 2012;38(2):149-55
   PubMed Web of Science ®Google Scholar
• Chang K . Comorbidities, quality of life and patients’ willingness to pay for a cure for type 2 diabetes in Taiwan. Public Health 2010;124(5):284-94
   PubMed Web of Science ®Google Scholar
• Caughey GE , Roughead EE , Vitry AI , et al. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010;87(3):385-93
   PubMed Web of Science ®Google Scholar
• Poulsen MK , Henriksen JE , Dahl J , et al. Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients. J Nucl Cardiol 2009;16(6):878-87
   PubMed Web of Science ®Google Scholar
• Suh DC , Kim CM , Choi IS , Plauschinat CA . Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc 2008;56(3):484-92
   PubMed Web of Science ®Google Scholar
• Piazza G , Goldhaber SZ , Kroll A , et al. Venous thromboembolism in patients with diabetes mellitus. Am J Med 2012;125(7):709-16
   PubMed Web of Science ®Google Scholar
• Pelletier EM , Shim B , Ben-Joseph R , Caro JJ . Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pharmacoeconomics 2009;27(6):479-90
   PubMed Web of Science ®Google Scholar
• Mody R , Kalsekar I , Kavookjian J , et al. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. J Diabetes Complications 2007;21(2):75-83
   PubMed Web of Science ®Google Scholar
• Gandra SR , Lawrence LW , Parasuraman BM , et al. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006;12(7):546-54
   PubMed Web of Science ®Google Scholar
• Erwin G , Iyer S , Rajagopalan R , et al. Type 2 diabetes mellitus treatment patterns and healthcare costs in the elderly population. Dis Manag Health Outcomes 2006;14(2):75-83
   Google Scholar
• Brandle M , Zhou H , Smith BR , et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26(8):2300-4
   PubMed Web of Science ®Google Scholar
• Li R , Bilik D , Brown MB , et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care 2013;19(5):421-30
   PubMed Web of Science ®Google Scholar
• Straka RJ , Liu LZ , Girase PS , et al. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol 2009;8:53
   PubMed Web of Science ®Google Scholar
• Hogan P , Dall T , Nikolov P , American Diabetes A . Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26(3):917-32
   PubMed Web of Science ®Google Scholar
• O’Brien JA , Shomphe LA , Kavanagh PL , et al. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 1998;21(7):1122-8
   PubMed Web of Science ®Google Scholar
• Pelletier EM , Smith PJ , Boye KS , et al. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 2008;6(2–3):103-12
   PubMedGoogle Scholar
• Dworkin RH , Malone DC , Panarites CJ , et al. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain 2010;11(4):360-8
   PubMed Web of Science ®Google Scholar
• Gordois A , Scuffham P , Shearer A , et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26(6):1790-5
   PubMed Web of Science ®Google Scholar
• Nichols GA , Vupputuri S , Lau H . Medical care costs associated with progression of diabetic nephropathy. Diabetes Care 2011;34(11):2374-8
   PubMed Web of Science ®Google Scholar
• Burke J , Kovacs B , Borton L , Sander S . Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment. Postgrad Med 2012;124(2):77-91
   PubMed Web of Science ®Google Scholar
• O’Brien JA , Patrick AR , Caro J . Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003;25(3):1017-38
   PubMed Web of Science ®Google Scholar
• Brown JB , Pedula KL , Bakst AW . The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159(16):1873-80
   PubMedGoogle Scholar
• Caro JJ , Ward AJ , O’Brien JA . Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 2002;25(3):476-81
   PubMed Web of Science ®Google Scholar
• Davidov E , Breitscheidel L , Clouth J , et al. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol 2009;247(2):267-72
   PubMed Web of Science ®Google Scholar
• Glasgow RE , Ruggiero L , Eakin EG , et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997;20(4):562-7
   PubMed Web of Science ®Google Scholar
• Julius U , Gross P , Hanefeld M . Work absenteeism in type 2 diabetes mellitus: results of the prospective Diabetes Intervention Study. Diabete Metab 1993;19(1 Pt 2):202-6
   PubMedGoogle Scholar
• de Visser CL , Bilo HJ , Groenier KH , et al. The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual Life Res 2002;11(3):249-61
   PubMed Web of Science ®Google Scholar
• Venskutonyte L , Brismar K , Ohrvik J , et al. Self-rated health predicts outcome in patients with type 2 diabetes and myocardial infarction: a DIGAMI 2 quality of life sub-study. Diab Vasc Dis Res 2013;10(4):361-7
   PubMed Web of Science ®Google Scholar
• Venkataraman K , Wee HL , Leow MK , et al. Associations between complications and health-related quality of life in individuals with diabetes. Clin Endocrinol (Oxf) 2013;78(6):865-73
   PubMed Web of Science ®Google Scholar
• Green AJ , Bazata DD , Fox KM , Grandy S . Quality of life, depression, and healthcare resource utilization among adults with type 2 diabetes mellitus and concomitant hypertension and obesity: a prospective survey. Cardiol Res Pract 2012;2012:404107
   PubMedGoogle Scholar
• Solli O , Stavem K , Kristiansen IS . Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18
   PubMed Web of Science ®Google Scholar
• Lloyd A , Sawyer W , Hopkinson P . Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001;4(5):392-400
   PubMedGoogle Scholar
• Van Acker K , Bouhassira D , De Bacquer D , et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009;35(3):206-13
   PubMed Web of Science ®Google Scholar
• Cong JY , Zhao Y , Xu QY , et al. Health-related quality of life among Tianjin Chinese patients with type 2 diabetes: a cross-sectional survey. Nurs Health Sci 2012;14(4):528-34
   PubMed Web of Science ®Google Scholar
• Chyun DA , Melkus GD , Katten DM , et al. The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs 2006;7(4):279-88
   PubMed Web of Science ®Google Scholar
• Mazhar K , Varma R , Choudhury F , et al. Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology 2011;118(4):649-55
   PubMed Web of Science ®Google Scholar
• Fenwick EK , Xie J , Ratcliffe J , et al. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53(2):677-84
   PubMed Web of Science ®Google Scholar
• Ragnarson Tennvall G , Apelqvist J . Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000;14(5):235-41
   PubMed Web of Science ®Google Scholar
• Zhang P , Brown MB , Bilik D , et al. Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35(11):2250-6
   PubMed Web of Science ®Google Scholar
• McEwen LN , Karter AJ , Waitzfelder BE , et al. Predictors of mortality over 8 years in type 2 diabetic patients: translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35(6):1301-9
   PubMed Web of Science ®Google Scholar
• Chyun D , Vaccarino V , Murillo J , et al. Acute myocardial infarction in the elderly with diabetes. Heart Lung 2002;31(5):327-39
   PubMed Web of Science ®Google Scholar
• Chyun D , Vaccarino V , Murillo J , et al. Cardiac outcomes after myocardial infarction in elderly patients with diabetes mellitus. Am J Crit Care 2002;11(6):504-19
   PubMed Web of Science ®Google Scholar
• Koek HL , Soedamah-Muthu SS , Kardaun JW , et al. Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol 2007;22(12):883-8
   PubMed Web of Science ®Google Scholar
• Lin EH , Heckbert SR , Rutter CM , et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009;7(5):414-21
   PubMed Web of Science ®Google Scholar
• The University Group Diabetes Program . A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy. Diabetes 1975;24(Suppl 1):65-184
   PubMedGoogle Scholar
• Zhang XD , Chen YR , Ge L , et al. Features of stroke in Chinese diabetes patients: a hospital-based study. J Int Med Res 2007;35(4):540-6
   PubMed Web of Science ®Google Scholar
• Braun KF , Otter W , Sandor SM , et al. All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke. Diabetes Res Clin Pract 2012;98(1):164-8
   PubMed Web of Science ®Google Scholar
• Jancaityte L , Rastenyte D . Short-term and one-year prognosis of diabetic patients with a first-ever myocardial infarction. Medicina (Kaunas) 2007;43(7):555-61
   PubMed Web of Science ®Google Scholar
• Scirica BM , Bhatt DL , Braunwald E , et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013;369(14):1317-26
   PubMed Web of Science ®Google Scholar
• White WB , Cannon CP , Heller SR , et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369(14):1327-35
   PubMed Web of Science ®Google Scholar
• Morgan CL , Mukherjee J , Jenkins-Jones S , et al. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab 2014;16(10):957-62
   PubMed Web of Science ®Google Scholar